We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PRVCF market cap is 8.83M. The company's latest EPS is CAD -0.0028 and P/E is -7.14.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 19k | 68k | 23k | 0 | 0 |
Operating Income | -6.07M | -2.89M | -1.82M | -505k | -697k |
Net Income | -11.88M | -3.58M | -3.8M | -1.73M | -1.48M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 1.9M | 857k | 302k | 161k | 189k |
Total Liabilities | 4.19M | 5.34M | 3.91M | 4.27M | 4.82M |
Total Equity | -2.29M | -4.49M | -3.6M | -4.1M | -4.64M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -7.57M | -994k | 64k | -426k | -223k |
Investing | -11k | -1,000 | -2k | -52k | 1,000 |
Financing | 7.55M | 867k | 183k | 137k | 212k |
Market Cap | 8.83M |
Price to Earnings Ratio | -7.14 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | -2.31 |
Dividend Yield | - |
Shares Outstanding | 535.3M |
Average Volume (1 week) | 33.36k |
Average Volume (1 Month) | 50.55k |
52 Week Change | 16.20% |
52 Week High | 0.025 |
52 Week Low | 0.011 |
Spread (Intraday) | 0 (17.88%) |
Company Name | PreveCeutical Medical Inc (QB) |
Address |
595 howe street 10 floor vancouver, british columbia V6C 2T5 |
Website | https://www.preveceutical.com |
Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions